DETAILED ACTION
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention.
Claim(s) 1-2, 6 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kaisha (WO 03/088116 A1).
Regarding Claims 1-2, 6, Kaisha teaches a material represented by Compd 4 (page 11):
PNG
media_image1.png
244
460
media_image1.png
Greyscale
Compd 4 reads on applicants Formula 1 and 1-1 and wherein R1 = substituted heteroaryl; R2 = ethyl (per claims 1-2)
Allowable Subject Matter I
Claims 3-5 and 7 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims.
The prior art fails to show:
-HAr (per claims 4-5)
Compounds (per claim 7)
Allowable Subject Matter II
The following is a statement of reasons for the indication of allowable subject matter as applicant claims a plurality of host represented by Formula 1 and Formula 2.
A search of the prior art fails to show the limitations of independent claim 8. The closest prior art as exemplified by:
Kaisha teaches a material represented Compd 4 which reads on applicants’ Formula 1, as discussed above. Kaisha fails to teach 3a as a host in a combination reading on applicants’ Formula 1 and Formula 3.
Cho (US 2020/0028089 A1) teaches an organic electroluminescent device according to the present disclosure comprises an anode; a cathode; and at least one organic layer between the anode and the cathode. The organic layer comprises a light-emitting layer comprising a host and a phosphorescent dopant. The host comprises a plurality of host compounds, at least a first host compound of the plurality of host compounds represented by Formula 1 or Formula 2 (first host) and the second host (Formula 3) (paragraph 50). Cho’s Formula 1 and Formula 2 is shown below:
..
PNG
media_image2.png
377
966
media_image2.png
Greyscale
PNG
media_image3.png
780
777
media_image3.png
Greyscale
The office notes that Cho’s Formula 2 shows applicants’ A as a naphthyl group and R2 as an amino group but lacks the required selenium atom. Cho’s Formula 2 reads on applicants’ Formula 2 wherein X1 and Y1 can be NR, =N-, O or S; the amino group shows options points of attachment. Cho fails to teach the combination of applicants’ Formula 1 and 2 as required by independent claim 8.
Kaisha and Cho fail to teach, suggest or offer guidance that would render it obvious modify the exemplified compounds to arrive at combination of independent claim 8.
Claims 8-9 allowed.
Allowable Subject Matter III
The following is a statement of reasons for the indication of allowable subject matter as applicant claims a plurality of host represented by Formula 1 and Formula 3.
The closest prior art as exemplified by Kaisha teaches Compd 4 which reads on applicants’ Formula 1, as discussed above. Kaisha fails to teach a combination of 3a and applicants’ Formula 3.
Claims 10-15 allowed.
Allowable Subject Matter IIII
The following is a statement of reasons for the indication of allowable subject matter as applicant claims a plurality of host represented by Formula 1 and Formula 4, as required by independent claim 16.
A search of the prior art fails to show the limitations of independent claim 10. The closest prior art as exemplified by Kaisha teaches Compd 4 which reads on applicants’ Formula 1, as discussed above. Kaisha fails to teach 3a as a combination with applicants’ Formula 4. The closest prior art:
Kim (US 2017/0309841) teaches a plurality of host including a metal complex and a heterocycle compound (paragraph 8). The heterocycle is represented by H2-37 (page 21):
PNG
media_image4.png
330
384
media_image4.png
Greyscale
H2-37 reads on applicants’ Formula 4 wherein Ar10 is benzopyrimidine; L100 is a single bond; V = NX13, X13 is phenyl; X101 and X102 = H.
While Kim teaches applicants’ Formula 4, Kim fails to teach a combination with applicants’ Formula 1 as required by independent claim 16
Claims 16-17 allowed.
Allowable Subject Matter V
The following is a statement of reasons for the indication of allowable subject matter as applicant claims a plurality of host represented by Formula 1 and Formula 5, as required by independent claim 18. The closest prior art:
Kaisha teaches Compd 4, as discussed above. Kaisha fails to teach Compd 4 as a host material in a combination with applicants’ Formula 5.
Kim II (US 2018/0182973 A1) teaches a plurality of host compounds (paragraph 7) one of the host is represented by H1-17 (page 7):
PNG
media_image5.png
444
307
media_image5.png
Greyscale
H1-17 reads on applicants’ Formula 5 wherein Ar = carbazole; Lr = biphenylene; Lq = single bond; Arq = phenyl; Lp = phenylene; T = 5-1; R6-R8 = H.
Kim II fails to teach H1-17 in a combination with applicants’ Formula 1 as required by independent claim 18.
Claims 18-20 allowed.
Allowable Subject Matter VI
The following is a statement of reasons for the indication of allowable subject matter as applicant claims the devices of independent claims 21, 22, 23, 24, and 25.
A search of the prior art did not show the claimed invention. As each of the independent claims require an OLED containing applicants’ Formula 1 and Kaisha fails to teach an OLED containing 3a as required by the limitations of independent claims 21, 22, 23, 24, and 25.
Claims 21-25 allowed.
Conclusion
Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to GREGORY D CLARK whose telephone number is (571)270-7087. The examiner can normally be reached on 8AM-4PM M-F.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Chriss can be reached on 571-272-7783. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/GREGORY D CLARK/Primary Examiner, Art Unit 1786
Prosecution Insights